CAPN10-AS1 Gene

Name CAPN10 antisense RNA 1 (head to head)
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Recent integrative analyses of diverse diseases have revealed critical roles for long noncoding RNAs in modulating gene expression and disease progression. Notably, in the context of HBV‐associated hepatocellular carcinoma, CAPN10‑AS1 has emerged as a promising diagnostic and prognostic biomarker. In one comprehensive study, CAPN10‑AS1 was identified among five optimal lncRNA biomarkers that distinguished tumor from adjacent tissues, with its expression strongly correlated with a network of 105 differentially expressed mRNAs. Functional annotation of these co‐expressed genes implicated key pathways—most notably the Jak‑STAT signaling pathway and retinol metabolism—that may underlie its involvement in hepatocarcinogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n While additional studies have advanced our understanding of RNA metabolism, cancer driver identification, and tissue responses in chronic conditions"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "4"}]}, {"type": "t", "text": ", CAPN10‑AS1 specifically stands out in the HBV‑associated HCC setting. Its differential expression and co‐regulation with cancer‐associated mRNAs suggest that it may influence key oncogenic signaling cascades, providing a new molecular handle for early detection and potential therapeutic targeting in liver cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yonghua Mou, Dongguo Wang, Renwei Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-181424"}], "href": "https://doi.org/10.3233/CBM-181424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29991128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29991128"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Toomas Silla, Manfred Schmid, Yuhui Dou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkz1238"}], "href": "https://doi.org/10.1093/nar/gkz1238"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31950173"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31950173"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wenbin Zhou, Zhangxiang Zhao, Ruiping Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of driver copy number alterations in diverse cancer types and application in drug repositioning."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12112"}], "href": "https://doi.org/10.1002/1878-0261.12112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28719033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28719033"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Eri Takematsu, Adrianne Spencer, Jeff Auster, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome wide analysis of gene expression changes in skin from patients with type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0225267"}], "href": "https://doi.org/10.1371/journal.pone.0225267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32084158"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32084158"}]}]}]}
Synonyms LOCUS959, CAPN10-DT
NCBI Gene ID 101752400
API
Download Associations
Predicted Functions View CAPN10-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View CAPN10-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CAPN10-AS1's ARCHS4 Predicted Functions.

Functional Associations

CAPN10-AS1 has 481 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 5 datasets.

Click the + buttons to view associations for CAPN10-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of CAPN10-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of CAPN10-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of CAPN10-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CAPN10-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with CAPN10-AS1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.